data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
NeoGenomics
(NASDAQ:NEO)
$8.81
At close: Jul 6
$8.81
PreMarket: 4:01PM EDT
Day High/Low- - -
52 Week High/Low6.85 - 54.74
Open / Close- / -
Float / Outstanding90.1M / 124.8M
Vol / Avg.- / 2.3M
Mkt Cap1.1B
P/E-
50d Avg. Price8.6
Div / Yield-
Payout Ratio-
EPS-0.4
Total Float90.1M

NeoGenomics (NASDAQ:NEO), Quotes and News Summary

NeoGenomics (NASDAQ: NEO)

Day High/Low- - -
52 Week High/Low6.85 - 54.74
Open / Close- / -
Float / Outstanding90.1M / 124.8M
Vol / Avg.- / 2.3M
Mkt Cap1.1B
P/E-
50d Avg. Price8.6
Div / Yield-
Payout Ratio-
EPS-0.4
Total Float90.1M
Benzinga - Sponsored
Benzinga - Jun 3, 2022, 4:59AM
Benzinga - Apr 28, 2022, 11:36AM
Benzinga - Apr 28, 2022, 5:40AM
Benzinga - Apr 27, 2022, 7:26AM
Benzinga - Apr 27, 2022, 7:25AM
Benzinga - Apr 25, 2022, 7:06AM
Benzinga - Apr 18, 2022, 4:40AM
Benzinga - Apr 12, 2022, 10:15AM
Benzinga - Apr 11, 2022, 10:01AM
Benzinga - Mar 29, 2022, 11:30AM
Benzinga - Mar 29, 2022, 9:50AM
Benzinga - Mar 29, 2022, 9:39AM
Sector: Health Care.Industry: Life Sciences Tools & Services
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-05
REV
Q1 2022Est.ActualSurprise
EPS-0.230-0.200 0.0300
REV116.680M117.169M489.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

NeoGenomics Questions & Answers

Q
How do I buy NeoGenomics (NEO) stock?
A

You can purchase shares of NeoGenomics (NASDAQ: NEO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are NeoGenomics's (NEO) competitors?
Q
What is the target price for NeoGenomics (NEO) stock?
A

The latest price target for NeoGenomics (NASDAQ: NEO) was reported by Piper Sandler on Friday, June 3, 2022. The analyst firm set a price target for 13.00 expecting NEO to rise to within 12 months (a possible 47.56% upside). 21 analyst firms have reported ratings in the last year.

Q
Current Stock Price for NeoGenomics (NEO)?
A

The stock price for NeoGenomics (NASDAQ: NEO) is $8.81 last updated July 6, 2022, 8:00 PM UTC.

Q
Does NeoGenomics (NEO) pay a dividend?
A

There are no upcoming dividends for NeoGenomics.

Q
When is NeoGenomics (NASDAQ:NEO) reporting earnings?
A

NeoGenomics’s Q2 earnings are confirmed for Friday, August 5, 2022.

Q
Is NeoGenomics (NEO) going to split?
A

There is no upcoming split for NeoGenomics.

Q
What sector and industry does NeoGenomics (NEO) operate in?
A

NeoGenomics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.